Search Results - "Antonopoulos, A S"

Refine Results
  1. 1

    From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease by Antonopoulos, A. S., Oikonomou, E. K., Antoniades, C., Tousoulis, D.

    Published in Obesity reviews (01-10-2016)
    “…Summary Despite a strong association between body weight and mortality in the general population, clinical evidence suggests better clinical outcome of…”
    Get full text
    Journal Article
  2. 2

    Adiponectin: from obesity to cardiovascular disease by Antoniades, C, Antonopoulos, A.S, Tousoulis, D, Stefanadis, C

    Published in Obesity reviews (01-05-2009)
    “…Adiponectin is an adipokine whose biosynthesis is deranged in obesity and diabetes mellitus, predisposing to atherosclerosis. Evidence suggests that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease by Michaelides, A P, Soulis, D, Antoniades, C, Antonopoulos, A S, Miliou, A, Ioakeimidis, N, Chatzistamatiou, E, Bakogiannis, C, Marinou, K, Liakos, C, Stefanadis, C

    Published in Heart (British Cardiac Society) (01-05-2011)
    “…Exercise improves the clinical outcome of patients with coronary artery disease (CAD); however, the ideal exercise duration for each patient remains unclear…”
    Get more information
    Journal Article
  5. 5

    Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials by Antoniades, Charalambos, Antonopoulos, Alexios S., Tousoulis, Dimitris, Marinou, Kyriakoula, Stefanadis, Christodoulos

    Published in European heart journal (01-01-2009)
    “…Plasma total homocysteine (Hcy) has been associated with cardiovascular risk in multiple large-scale epidemiological studies, and it has been considered as an…”
    Get full text
    Journal Article
  6. 6

    Comprehensive mitral valve prolapse assessment by cardiovascular MRI by Musella, F., Azzu, A., Antonopoulos, A.S., La Mura, L., Mohiaddin, R.H.

    Published in Clinical radiology (01-02-2022)
    “…Mitral valve (MV) prolapse (MVP) is a not fully understood common MV disorder. The development of sophisticated cardiovascular magnetic resonance imaging…”
    Get full text
    Journal Article
  7. 7
  8. 8

    PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis by Theofilis, P, Papanikolaou, A, Vlachakis, P K, Antonopoulos, A S, Sagris, M, Oikonomou, E, Tsioufis, K, Tousoulis, D

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have emerged as a promising class of medications, primarily recognized…”
    Get full text
    Journal Article
  9. 9

    Anti-inflammatory potential of SGLT2 inhibitors: a systematic review and meta-analysis of preclinical studies in rodents by Theofilis, P, Sagris, M, Oikonomou, E, Antonopoulos, A S, Siasos, G, Tsioufis, K, Tousoulis, D

    Published in European heart journal (03-10-2022)
    “…Abstract Background Sodium-glucose cotransporter-2 (SGLT2) inhibition is at the forefront of scientific research due to their astonishing effect in…”
    Get full text
    Journal Article
  10. 10

    Pericardiocentesis vs conservative management in patients with asymptomatic, chronic, large, idiopathic, C-reactive negative pericardial effusion by Lazarou, E, Lazaros, G, Antonopoulos, A S, Karavidas, A, Tsioufis, C, Tousoulis, D, Vlachopoulos, C

    Published in European heart journal (12-10-2021)
    “…Abstract Background/Introduction Pericardial effusion (PE) prognosis largely depends on the underlying etiology. Purpose We sought to assess the outcome of…”
    Get full text
    Journal Article
  11. 11

    The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis by Theofilis, P, Vlachakis, P K, Antonopoulos, A S, Sagris, M, Mantzouranis, E, Sakalidis, A, Oikonomou, E, Siasos, G, Tsioufis, K, Tousoulis, D

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as a groundbreaking class of antidiabetic medications, renowned for their…”
    Get full text
    Journal Article
  12. 12

    Evaluation of aortic inflammation in marfan syndrome patients with 18-fluorodeoxyglucose positron emission and computed tomography by Goliopoulou, A, Oikonomou, E, Gkotzamanis, V, Kafouris, P, Mystakidi, V C, Sakalidis, A, Antonopoulos, A S, Siasos, G, Anagnostopoulos, C, Tsioufis, K, Brili, S V

    Published in European heart journal (28-10-2024)
    “…Abstract Background The role of inflammation in Marfan Syndrome (MS) has been well studied in current research. These studies have investigated the role of…”
    Get full text
    Journal Article
  13. 13

    Prognostic value of myocardial redox signalling: a machine learning multi-omics approach by Kotanidis, C P, Akawi, N, Chauhan, J, Polkinghorne, M, Akoumianakis, I, Antonopoulos, A S, Foran, D, Badi, I, Farid, S, Srivastava, V, Krasopoulos, G, Sayeed, R, Channon, K M, Antoniades, C

    Published in European heart journal (28-10-2024)
    “…Abstract Background Oxidative stress has been proposed to be implicated in cardiovascular pathology. Studies have linked myocardial oxidative stress with the…”
    Get full text
    Journal Article
  14. 14

    Pericoronary adipose tissue attenuation index (FAI) and its cardiovascular diagnostic and prognostic utility: a systematic review and meta-analysis by Sagris, M, Antonopoulos, A S A, Simantiris, S S, Oikonomou, E O, Siasos, G S, Tsioufis, K T, Tousoulis, D T

    Published in European heart journal (03-10-2022)
    “…Abstract Background Pericoronary fat attenuation index (FAI) on coronary computed tomography angiography (CCTA) imaging has been proposed as a novel marker of…”
    Get full text
    Journal Article
  15. 15

    The natural history of idiopathic chronic large asymptomatic non-inflammatory pericardial effusions by Lazaros, G, Lazarou, E, Valatsou, A, Vlachopoulos, C, Antonopoulos, A S, Dimitroglou, Y, Sakalidis, A, Tsioufis, P, Kachrimanidis, I, Tsioufis, C

    Published in European heart journal (03-10-2022)
    “…Abstract Background/Introduction Pericardial effusions (PEFs) are a challenging and often troublesome pericardial syndrome. The most recent 2015 ESC guidelines…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Development of a risk-score for pericarditis recurrence in patients with a first episode of acute pericarditis by Lazarou, E, Lazaros, G, Antonopoulos, A S, Imazio, M, Vasileiou, P, Karavidas, A, Toutouzas, K, Vassilopoulos, D, Tsioufis, C, Tousoulis, D, Vlachopoulos, C

    Published in European heart journal (12-10-2021)
    “…Abstract Background/Introduction Currently we remain uncertain about which patients are at increased risk for recurrent pericarditis. Purpose We developed a…”
    Get full text
    Journal Article
  18. 18

    2229Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes by Zacharia, E, Papageorgiou, N, Antonopoulos, A S, Pallantza, Z, Oikonomou, E, Miliou, A, Mistakidi, C V, Kriebardis, A, Orologas, N, Valasiadi, E, Papaioannou, S, Tousoulis, D

    Published in European heart journal (01-10-2019)
    “…Abstract Background Circulating microparticles (MP) are surrogate biomarkers of atherosclerosis but their role in patients with acute coronary syndromes (ACS)…”
    Get full text
    Journal Article
  19. 19

    P4392A systematic review and meta-analysis of the cardiovascular effects of e-cigarette by Antonopoulos, A S, Skotsimara, G, Oikonomou, E, Ioakeimidis, N, Mistakidi, C V, Georgakopoulos, C, Galiatsatos, N, Charalampous, G, Vlachopoulos, C, Tousoulis, D

    Published in European heart journal (01-10-2019)
    “…Abstract Background Electronic cigarette (EC) is marketed as a safe alternative to tobacco smoking, but EC cardiovascular effects remains largely unknown…”
    Get full text
    Journal Article
  20. 20

    P1573Chemotherapy-induced vasotoxicity in patients undergoing therapy for breast cancer by Anastasiou, M, Antonopoulos, A S, Oikonomou, E, Zagouri, F, Siasos, G, Vogiatzi, G, Tsalamandris, S, Mistakidi, C V, Psaltopoulou, T, Bamias, A, Dimopoulos, M, Tousoulis, D

    Published in European heart journal (01-10-2019)
    “…Abstract Background Cardiotoxicity is a well-known adverse effect of anthracycline and HER-2 monoclonal antibodies, however the vascular effects of these…”
    Get full text
    Journal Article